# Efficacy of Different Treatment Regimens With Chitosan-N- Acetylcysteine in Moderate-to-severe Dry Eye Disease

> **NCT05053789** · NA · TERMINATED · sponsor: **Vienna Institute for Research in Ocular Surgery** · enrollment: 48 (actual)

## Conditions studied

- Eye Diseases

## Interventions

- **DEVICE:** Lacrimera
- **DEVICE:** Hylo-Vision

## Key facts

- **NCT ID:** NCT05053789
- **Lead sponsor:** Vienna Institute for Research in Ocular Surgery
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-12
- **Primary completion:** 2021-08-27
- **Final completion:** 2021-08-27
- **Target enrollment:** 48 (ACTUAL)
- **Why stopped:** Medical device expired
- **Last updated:** 2021-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05053789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05053789, "Efficacy of Different Treatment Regimens With Chitosan-N- Acetylcysteine in Moderate-to-severe Dry Eye Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05053789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*